Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes. Read more about Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes.
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer. Read more about A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Read more about Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Read more about Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.
Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer. Read more about Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Read more about Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
Circulating tumor cells in breast cancer: applications in personalized medicine. Read more about Circulating tumor cells in breast cancer: applications in personalized medicine.
Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013. Read more about Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013.
Breast cancer risk prediction using a clinical risk model and polygenic risk score. Read more about Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors. Read more about Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.
